期刊文献+

益气健脾抗癌中药对胃癌裸鼠肝肾脏蛋白激酶C影响的实验研究 被引量:4

Chinese medicine with replenishing qi and invigorating spleen effects on protein kinase C activity in liver and kidney of nude mice with gastric cancer
原文传递
导出
摘要 目的探讨益气健脾抗癌中药对胃癌裸鼠肝脏和肾脏蛋白激酶C活性的影响。方法在40只裸小鼠中随机选取30只腋下接种人胃癌SGC-7901细胞株,将成瘤裸鼠随机分为模型组、补脾对照组和补脾抗癌组,每组10只,剩余10只未种瘤裸鼠设为空白组。空白组和模型组予0.9%NaCl溶液灌胃,补脾对照组予益气健脾中药灌胃,补脾抗癌组予益气健脾合抗癌中药灌胃。各组给予相应的干预措施14天,观察动物的肝肾组织大体情况并称重,计算脏器系数,用Western Blot法检测肝脏和肾脏PKC活性。结果与空白组比较,模型组瘤鼠肝系数、肾系数降低,差异有统计学意义(P<0.05);与模型组比较,补脾对照组和补脾抗癌组肝系数、肾系数升高,差异有统计学意义(P<0.05)。同时模型组肝脏和肾脏PKC活性较空白组明显升高,补脾对照组和补脾抗癌组裸鼠肝脏和肾脏中PKC活性较模型组均下降(P<0.01),其中补脾抗癌组较补脾对照组下降更为显著(P<0.01)。结论胃癌瘤鼠存在脾虚症状,益气健脾和益气健脾抗癌中药对胃癌裸鼠体质量、肝重、肾重、肝系数、肾系数,以及肝脏和肾脏中PKC活性均具有调节作用,且益气健脾抗癌中药对PKC的调节作用优于益气健脾中药。 Objective To discuss the effect of Chinese medicine on protein kinase C (PKC) activity in liver and kidney of nude mice with stomach cancer. Methods Thirty nude mice out of 40 were selected randomly and armpit inoculated with human gastric cancer cells SGC-7901. The nude mice were randomly divided into model group, tonifying spleen control group and tonifying spleen anticancer group, with 10 mice in each group. The rest of 10 mice were divided into blank group. The mice in blank group and model group were treated with normal saline, tonifying spleen control group was treated with Chinese medicine with replenishing qi effect, tonifying spleen anticancer group was treated with Chinese medicine with combined replenishing qi and anticancer effects, with 0.8 ml each and for 14 days by garage. The condition of the liver and kidney tissue were observed and the weights were measured. The organ coefficients were counted and the PKC activities in liver and kidney were tested by Western Blot method. Results Compared with blank group, the liver coefficient and kidney coefficient in model group were decreased, with significant difference between the two groups ( P 〈 0.05 ) ; compared with model group, the liver coefficient and kidney coefficient in tonifying spleen control group and tonifying spleen anticancer group were increased significantly ( P 〈 0.05 ). The PKC activities in liver and kidney of the model group were significantly higher than that of the blank group. After treatment, the PKC activities in liver and kidney of the tonifying spleen group and tonifying spleen anticancer group were lower than that of the model group, and the PKC activity in tonifying spleen anticancer group was lower than that of the tonifying spleen control group significantly ( P 〈 0.01 ). Conclusion Spleen deficiency symptom is very common in mice with gastric cancer. Chinese medicine has regulatory effect on the body weight, fiver weight, kidney weight, liver coefficient, kidney coefficient and PKC activities in nude mice. Moreover, the Chinese medicine with replenishing spleen qi and anticancer effects has better regulatory effect on PKC activities than that with replenishing spleen qi effect.
出处 《上海中医药杂志》 2013年第10期74-77,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 辽宁中医药大学附属医院科研骨干项目
关键词 胃癌 益气健脾 抗癌 蛋白激酶C replenishing qi and invigorating spleen anticancer Chinese medicine gastric cancer protein kinase C (PKC)
  • 相关文献

参考文献16

二级参考文献97

共引文献264

同被引文献45

  • 1何燕清.抗癌解毒增效方对实验肿瘤化疗的减毒增敏作用[J].中医杂志,2004,45(11):825-825. 被引量:1
  • 2朱颖,殷东风.运用调理脾胃中药提高晚期肿瘤患者生存质量的临床分析[J].中国中医基础医学杂志,2006,12(9):685-687. 被引量:33
  • 3关崇芬,沈华.蛋白酪氨激酶与中医脾虚证研究[J].中国中医药信息杂志,1996,3(11):14-14. 被引量:17
  • 4唐广义,殷东风.肠积宁方促进大肠癌细胞株HT-29凋亡及干预相关基因bcl-2及bax表达的实验研究[J].现代肿瘤医学,2007,15(4):491-493. 被引量:11
  • 5DOLLER A, WINKLER C, AZRILIAN I, et al. High-constitutive HuR phosphorylation at Ser 318 by PKC { delta} propagates tumor relevant functions in coloncarcinoma ceils [ J ]. Carcinogenesis, 2011, 32 (5) : 676-685. DOI : 10. 1093/carcin/bgr024.
  • 6LIM J H, WOO S M, MINK J, et al. Rottlerin induces apoptosis of HT29 colon carcinomacells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC independent mechanism [J~. Chem Biol Interact, 2012, 197(1) : 1-7. DOI:10. 1016/j. cbi. 2012.02. 003.
  • 7OKUWA H, KANNO T, FUJITA Y, et al. Sphingosine suppres- ses mesothelioma cell proliferation by inhibiting PKC-~ and indu- cing cell cycle arrest at the G(0)/G( 1 ) phase [J]. Cell Physiol Biochem, 2012, 30 (4) : 995-1004. DOI : 10.1159/000341476.
  • 8TOTOfi E, IGNATOWICZ E, SKRZECZKOWAKA K, et al. Pro- tein kinase Ce as a cancer marker and target for anticancer therapy [J].Pharmacol Rep, 2011, 63 ( 1 ) : 19-29. DOI: 10. 1016/ s1734-1140( 11 )70395-4.
  • 9JAIN K, BASU A. The multifunctional protein kinase C-8 in cancer development and progression[J]. Cancers ( Basel), 2014, 6(2) : 860-878. DOI: 10. 3390/cancers6020860.10. 3390/canc- ers6020860.
  • 10GARG R, BLANDO J. Activation of nuclear factor KB (NF-KB) in prostate cancer is mediated by protein kinase C epsilon( PKCeps- ilon) [J]. J Biol Chem, 2012, 287(44) : 37570-37582. DO1: 10. 1074/jbc. Ml12. 398925.

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部